---

A study of the effect of Baclofen on blood glucose level in alcohol dependence syndrome(ADS) patients at a tertiary care hospital

---

Original Article

Author Details : Bharadwaj G, Satyanarayana V, Shabeer D, Vishnu Vardhan G

Volume : 4, Issue : 1, Year : 2017

Article Page : 55-61

Suggest article by email

Get Permission

---

Abstract

Background: Alcohol dependence syndrome affects an individual at physiological, behavioral, and cognitive level and include symptoms like withdrawal, tolerance, and craving. Heavy alcohol intake is often associated with many health related and social problems which poses a threat to the society. Recently Baclofen has been used to reduce the symptoms of ADS, and is shown to affect the level of blood glucose in patients receiving it.
Objective: The main objective of the study is to find out the effect of baclofen on blood glucose levels in ADS patients during therapy.
Methodology: A Prospective interventional study was designed and conducted in patients attending Psychiatry Department30 patients aged between 18 years and 60 years diagnosed with alcohol dependence syndrome (ADS) per ICD-10 criteria are enrolled in the study.
Blood glucose levels are checked at baseline, 10^th day and at 20^th day.
Results: Mean fasting blood glucose levels in patients was 87.1 mg/dl on day 0, 103.23mg/dl on day 1, 98.63 mg/dl on day 10 and 95.30 mg/dl on day 20.
Mean post prandial blood glucose was 125.5 mg/dl on day 0, 144.57mg/dl on day 1, 137.2 mg/dl on day 10 and 136.6 mg/dl on day 20.
Conclusion: Our study shows that Baclofen has a definite role in the levels of glucose, but the mechanism of action of depression in blood glucose levels is still unknown. Further studies are needed to confirm the long term effect of Baclofen on the blood glucose levels.

Keywords: Baclofen, Alcohol withdrawal syndrome, FBS, PPBS

How to cite : Bharadwaj G, Satyanarayana V, Shabeer D, Vishnu Vardhan G, A study of the effect of Baclofen on blood glucose level in alcohol dependence syndrome(ADS) patients at a tertiary care hospital. Indian J Pharm Pharmacol 2017;4(1):55-61

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.